I77.82
Antineutrophilic cytoplasmic antibody [ANCA] vasculitis
Clinical Classification Guidelines
Inclusion Terms
- ANCA associated vasculitis
- ANCA positive vasculitis
Excludes Type 2
- eosinophilic granulomatosis with polyangiitis (M30.1)
- granulomatosis with polyangiitis (M31.3-)
- microscopic polyangiitis (M31.7)
Medical Intelligence & Overview
Antineutrophilic Cytoplasmic Antibody (ANCA) Vasculitis is a rare autoimmune condition where the body's immune system mistakenly attacks small and medium-sized blood vessels. This inflammation can disrupt blood flow and damage organs and tissues. The condition is associated with the presence of ANCA antibodies in the blood, which target certain components within neutrophils, a type of white blood cell. Recognized under ICD-10 code I77.82, ANCA vasculitis requires medical evaluation and management, but understanding its features can help patients appreciate this complex disease.
Causes & Symptoms
Clinical Causes: The exact cause of ANCA vasculitis is unknown, but it involves an abnormal immune response. Genetic predisposition may play a role, with some individuals having inherited susceptibility. Environmental factors such as infections, certain drugs, or exposure to chemicals might trigger the immune system to produce ANCA antibodies. In some cases, the disease occurs alongside other autoimmune conditions. While the disease is not contagious, immune dysregulation is central to its development.
Key Symptoms: General symptoms such as fatigue, fever, and weight loss. Localized symptoms depending on affected organs, including: Sinusitis, nasal ulcers, or nosebleeds if the respiratory tract is involved. Shortness of breath, cough, or chest pain if lungs are affected. Blood in urine, kidney pain, or swelling indicating renal involvement. Skin rashes or ulcers through skin involvement. Muscle pain or nerve issues if nerves are affected.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of ANCA vasculitis involves several steps:
Treatment Protocols: Treating ANCA vasculitis aims to suppress the abnormal immune response and manage organ damage. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is I77.82 a billable ICD-10 code?
Yes, I77.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report I77.82?
Clinical documentation must specify the nature of Antineutrophilic cytoplasmic antibody [ANCA] vasculitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference